Home > Back to Publisher > Report Information

The US In Vitro Diagnostics Market Outlook: Strategic Implications of Emerging Reimbursement, Technological and Market Trends through 2018

Venture Planning Group
January 9, 2012
135 Pages - SKU: VPG6748479

Abstract Table of Contents Related Reports

Countries covered: United States

How will the future reimbursement changes affect individual market segments?

- Will the industry consolidate, decentralize, or undergo a bimodal transformation?

- What will be the impact on purchasing influences, marketing strategies, joint ventures, mergers, licensing, import and export?

- How will the future technological advances affect the major market segments?

- Which companies will enter the market and which will not survive?

These and other key strategic issues facing decision-makers are explored in this thought-provoking and multi-faceted portrait of the future U.S. in vitro diagnostics market.

This invaluable strategic planning resource is designed to help corporate, marketing and R&D executives develop effective business plans that best accommodate uncertainties ahead. The report evaluates emerging markets and technologies that may present unexpected threats or offer opportunities; identifies key strategic decisions that will have to be made in the future; and enhances corporate ability to develop realistic contingency plans.

The report presents strategic overview of the U.S. in vitro diagnostics market, including major regulatory, economic, demographic and social trends with potentially significant impact; as well as five- and ten-year test volume and sales forecasts for major testing locations (hospitals, commercial labs, physician offices, blood centers, POC sites, and others) and laboratory disciplines (blood banking, clinical chemistry, immunodiagnostics, coagulation, hematology, flow cytometry, histology, cytology, microbiology, serology, urinalysis and others).

Contains 135 pages and 11 tables

Please note: The delivery time for the electronic version of this report is between 1-3 business days to allow the preparation of an updated version prior to dispatch.

I. Executive Summary
2. Conclusions and Recommendations
3. Business Environment: a. Health Care Expenditures; b. Cost-Consciousness; c. Reimbursement; d. Industry Consolidation; e. Hospitals; f. Admissions; g. Length of Stay; h. Industry Diversification; i. Physician Demographics; j. Aging Population
4. Outlook for the In Vitro Diagnostics Market: a. Government Regulations; b. FDA Reform; c. Hospitals; d. Commercial Laboratories; e. Physician Offices; f. Point-of-Care Testing; g. Personal Testing; h. Other Testing Locations
5. Strategic Implications: a. Testing Patterns
6. Market Segments: a. Clinical Chemistry and Immunodiagnostics; b. Microbiology and Serology; c. Hematology and Flow Cytometry; d. Blood Banking; e. Histology and Cytology; f. Coagulation; g. Urinalysis
7. Technologies: a. Molecular Diagnostics; b. Monoclonal Antibodies; c. Solid Phase Chemistry; d. Biosensors and Biochips; e. Automation and Robotics; f. IT
8. The New Marketplace: a. Purchasing Influences; b. Marketing Strategies; c. Joint Venture, Merger, and Licensing Activity; d. Import-Export; e. Potential Market Entrants; f. Who May Not Survive
List of Tables: Executive Summary Table: Growth Areas in Clinical Laboratory Testing; Table-1: Estimated U.S. Health Care Expenditures By Expenditure Type; Table-2: Health Plan Enrollment Distribution; Table-3: Selected Hospital Statistics; Table-4: Total Population And Physician Demographics; Table-5: Test Volume By Location; Table-6: Test Distribution By Location; Table-7: Market Size By Location; Table-8: Typical Pre-Admission Tests; Table-9: Test Volume By Laboratory Discipline; Table-10: Market Size By Laboratory Discipline

More United States General In Vitro Diagnostics Reports

Strategic Implications of Technological and Market Trends for the US Diagnostics Industry by Venture Planning Group
How will the future reimbursement changes affect individual market segments? Will the industry consolidate, decentralize, or undergo a bimodal transformation? What will be the impact on purchasing ...

Strategic Implications of Innovative, Technological and Market Trends for the US Diagnostics Market by Venture Planning Group
How will the future reimbursement changes affect individual market segments? Will the industry consolidate, decentralize, or undergo a bimodal transformation? What will be the impact on purchasing ...

The 2012 Therapeutic Drug Monitoring Market: US, Europe, JapanTest Volume and Sales Forecasts by Country and Market Segment by Venture Planning Group
During the next decade, the TDM market will undergo significant transformation. These changes will be caused by convergence of new and more stringent regulations; ...

The 2012 Immunoprotein Diagnostics Market: US, Europe, JapanTest Volume and Sales Forecasts by Country and Market Segment by Venture Planning Group
During the next decade, the immunoprotein testing market will undergo significant transformation. The changes will be caused by convergence of new and more stringent ...

The 2012 Hepatitis Diagnostics Market: US, Europe, JapanTest Volume, Sales Forecasts and Supplier Shares by Country by Venture Planning Group
The report presents a detailed analysis of the Hepatitis diagnostics market in the US, Europe, (France, Germany, Italy, Spain, UK) and Japan. Current scientific ...

See all reports like this >>

More United States Reports

e-Discovery Software Publishing in the US - Industry Market Research Report by IBISWorld
e-Discovery Software Publishing in the US Finding growth : Electronic discovery (more often known as e-discovery) refers to a data search, location and securing process for use ...

D&B Country RiskLine Report: The United States of America by Dun & Bradstreet Inc.
This D&B Country RiskLine Report will help you analyze the risks, opportunities and likely payment delays when doing business in this country. It includes ...

D&B Country Report: The United States of America by Dun & Bradstreet Inc.
D&B Country Report. Comprehensive information for evaluating risks and opportunities when trading or investing in this country. Providing critical information and analysis on ...

Country Report United States January 2011 by Economist Intelligence Unit
Country Reports analyse political and economic trends in featured countries. They show you exactly how national, regional and global events will affect your business in ...

Coal - US - a snapshot (2010) by Mintel - Snapshots
Coal in US by Mintel Global Market Navigator provides you with annual year-end market size data, most recently updated in 2010. This market covers consumption ...

See all reports like this >>

The US In Vitro Diagnostics Market Outlook: Strategic Implications of Emerging Reimbursement, Technological and Market Trends through 2018

Share this report

Other tasks

Research Assistance

Related Markets

General In Vitro Diagnostics Reports

Free Alert Me service